OTRK vs. BRTX, MGRX, GBNHF, BIMI, PPBT, CHEK, COEP, AIKI, KPRX, and TRIB
Should you be buying Ontrak stock or one of its competitors? The main competitors of Ontrak include BioRestorative Therapies (BRTX), Mangoceuticals (MGRX), Greenbrook TMS (GBNHF), BIMI (BIMI), Purple Biotech (PPBT), Check-Cap (CHEK), Coeptis Therapeutics (COEP), AIkido Pharma (AIKI), Kiora Pharmaceuticals (KPRX), and Trinity Biotech (TRIB). These companies are all part of the "medical" sector.
BioRestorative Therapies (NASDAQ:BRTX) and Ontrak (NASDAQ:OTRK) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, media sentiment, analyst recommendations, institutional ownership, community ranking, risk and valuation.
Ontrak received 37 more outperform votes than BioRestorative Therapies when rated by MarketBeat users.
BioRestorative Therapies has higher earnings, but lower revenue than Ontrak. BioRestorative Therapies is trading at a lower price-to-earnings ratio than Ontrak, indicating that it is currently the more affordable of the two stocks.
Ontrak has a net margin of -219.10% compared to Ontrak's net margin of -9,873.97%. Ontrak's return on equity of -114.84% beat BioRestorative Therapies' return on equity.
BioRestorative Therapies has a beta of 62.12, suggesting that its share price is 6,112% more volatile than the S&P 500. Comparatively, Ontrak has a beta of 2.5, suggesting that its share price is 150% more volatile than the S&P 500.
In the previous week, BioRestorative Therapies had 7 more articles in the media than Ontrak. MarketBeat recorded 7 mentions for BioRestorative Therapies and 0 mentions for Ontrak. Ontrak's average media sentiment score of 0.06 beat BioRestorative Therapies' score of 0.00 indicating that BioRestorative Therapies is being referred to more favorably in the media.
Ontrak has a consensus target price of $4.00, indicating a potential upside of 1,435.51%. Given BioRestorative Therapies' higher possible upside, analysts clearly believe Ontrak is more favorable than BioRestorative Therapies.
69.4% of BioRestorative Therapies shares are held by institutional investors. Comparatively, 13.0% of Ontrak shares are held by institutional investors. 21.6% of BioRestorative Therapies shares are held by company insiders. Comparatively, 1.2% of Ontrak shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Summary
BioRestorative Therapies beats Ontrak on 10 of the 16 factors compared between the two stocks.
Get Ontrak News Delivered to You Automatically
Sign up to receive the latest news and ratings for OTRK and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding OTRK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
